Yi Liu

6PUBLICATIONS
18CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Proteomics and metabolomicsPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 27, 2026
A Novel Niclosamide Sulfate Prodrug with Enhanced Bioavailability Suppresses Hepatocellular Carcinoma via Inhibition of Multiple Signaling Pathways.

|Jan 28, 2026
Meteorin-like is associated with poor outcome in invasive candidiasis in mouse models and in humans.

Jiayu Liu, Hao Ding, Wang Tan

|Dec 03, 2025
Single-cell multi-omic landscape reveals anatomical-specific immune features in adult and pediatric sepsis.

Qian Ye, Xiaofei Lai, Yuliang Liu

|Oct 29, 2025
Magnetic Resonance Imaging Using a Chimeric Anti-Glypican-3 Antibody Conjugated with Gadolinium Selectively Detects Glypican-3-Positive Hepatocellular Carcinoma In Vitro and In Vivo.

Yi Liu, Mingdian Tan, Mei-Sze Chua

|Mar 19, 2024
Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice.

Yi Liu, David Quintanar Guerrero, David Lechuga-Ballesteros

|Jan 31, 2024
Bone morphogenetic protein 9 is a candidate prognostic biomarker and host-directed therapy target for sepsis.

Haobo Bai, Qian Lu, Chunxiang Wu

Pageof 1

Frequent Collaborators

3 joint publications

Ju Cao

2 joint publications

Jiayu Liu

2 joint publications

Xiaofei Lai

2 joint publications

Mei-Sze Chua